NCT00149409View on ClinicalTrials.gov

Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure

PHASE2/PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2005

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Chronic Heart Failure
Interventions
DIETARY_SUPPLEMENT

Omacor

Trial Locations (1)

A-1090

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT00149409 - Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure | Biotech Hunter | Biotech Hunter